Insights

Strategic Acquisition Kadmon's recent acquisition by Sanofi positions it within a robust global pharmaceutical ecosystem, offering opportunities to leverage Sanofi's extensive distribution channels and sales network for its innovative therapies in immuno-oncology and fibrotic diseases.

Pipeline Innovation With a pipeline featuring late-stage candidates like belumosudil and next-generation immuno-oncology fusion proteins, Kadmon presents potential sales opportunities in specialized therapeutic areas such as inflammatory, fibrotic, and cancer therapies, especially as these products advance through clinical trials.

Growing Market Presence Kadmon's focus on unmet medical needs in niche markets offers a unique positioning to engage healthcare providers and institutions seeking advanced treatment options in immuno-oncology and fibrotic diseases, expanding market penetration opportunities.

Technological Capabilities The company's use of advanced biotechnologies such as specific fusion proteins and targeted inhibitors indicates potential for collaboration with biotech and pharma partners looking to enhance their portfolio with innovative, scientifically validated solutions.

Regulatory and Funding Landscape Although current revenue ranges between 25 to 50 million dollars, Kadmon's strategic focus on late-stage clinical trials and recent acquisitions suggest upcoming opportunities for value-based selling and partnerships in regulatory support and commercialization.

Kadmon, a Sanofi Company Tech Stack

Kadmon, a Sanofi Company uses 8 technology products and services including Drupal, Twemoji, yepnope.js, and more. Explore Kadmon, a Sanofi Company's tech stack below.

  • Drupal
    Content Management System
  • Twemoji
    Font Scripts
  • yepnope.js
    Javascript Frameworks
  • jQuery UI
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • New Relic
    Real User Monitoring
  • Yoast SEO
    Search Engines
  • Adobe Tag Manager
    Tag Management

Media & News

Kadmon, a Sanofi Company's Email Address Formats

Kadmon, a Sanofi Company uses at least 1 format(s):
Kadmon, a Sanofi Company Email FormatsExamplePercentage
First.Last@kadmon.comJohn.Doe@kadmon.com
80%
First@kadmon.comJohn@kadmon.com
10%
Last@kadmon.comDoe@kadmon.com
9%
Fir.Last@kadmon.comJoh.Doe@kadmon.com
1%

Frequently Asked Questions

What is Kadmon, a Sanofi Company's phone number?

Minus sign iconPlus sign icon
You can contact Kadmon, a Sanofi Company's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Kadmon, a Sanofi Company's official website and social media links?

Minus sign iconPlus sign icon
Kadmon, a Sanofi Company's official website is kadmon.com and has social profiles on LinkedInCrunchbase.

What is Kadmon, a Sanofi Company's SIC code NAICS code?

Minus sign iconPlus sign icon
Kadmon, a Sanofi Company's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Kadmon, a Sanofi Company have currently?

Minus sign iconPlus sign icon
As of December 2025, Kadmon, a Sanofi Company has approximately 51 employees across 4 continents, including North AmericaAsiaAfrica. Key team members include Chief Medical Officer: J. R.Chief Operations Officer Coo): C. S.Vice President Clinical Operations: E. C.. Explore Kadmon, a Sanofi Company's employee directory with LeadIQ.

What industry does Kadmon, a Sanofi Company belong to?

Minus sign iconPlus sign icon
Kadmon, a Sanofi Company operates in the Biotechnology Research industry.

What technology does Kadmon, a Sanofi Company use?

Minus sign iconPlus sign icon
Kadmon, a Sanofi Company's tech stack includes DrupalTwemojiyepnope.jsjQuery UIUnderscore.jsNew RelicYoast SEOAdobe Tag Manager.

What is Kadmon, a Sanofi Company's email format?

Minus sign iconPlus sign icon
Kadmon, a Sanofi Company's email format typically follows the pattern of First.Last@kadmon.com. Find more Kadmon, a Sanofi Company email formats with LeadIQ.

Kadmon, a Sanofi Company

Biotechnology ResearchNew York, United States51-200 Employees

Kadmon, a Sanofi Company, is a biopharmaceutical company that discovers, develops and markets transformative therapies for unmet medical needs. Our team has a proven track record of successful drug development and commercialization. Our clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.

Our late-stage product candidate, belumosudil, is an orally administered selective inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2) in development for the treatment of inflammatory and fibrotic diseases. A pivotal study of belumosudil is underway in chronic graft-versus-host disease (cGVHD), as well as a Phase 2 study in systemic sclerosis. 

Kadmon is also developing next-generation immuno-oncology therapies, specifically IL-15 containing fusion proteins, for the treatment of cancer. Our lead I-O product candidate, KD033, is an anti-PD-L1/IL-15 fusion protein in a Phase 1 clinical trial. 

Comments are no longer monitored.

Section iconCompany Overview

Phone number
Website
kadmon.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $25M$50M

    Kadmon, a Sanofi Company's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    Kadmon, a Sanofi Company's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.